Pernod Ricard SA (RI.PA) Bundle
Pernod Ricard's latest numbers demand a close read: total sales for the year to June 30, 2025, were €10.96 billion (down 5.5% year‑on‑year) with organic net sales -3%, regional weakness in the Americas (-3%; US -6%), Asia & RoW (-7%; China -21%) and Europe (-4%), while management eyes a low single‑digit organic decline for FY25 and a H2 recovery-yet beneath the topline there are bright spots: profit from recurring operations of €2.95 billion (organic -0.8%) and EPS from recurring operations of €7.26 (about 3.9% above the €6.93 forecast), net income up 10% to €1.63 billion and a profit margin expanded to 15% (from 13%); balance‑sheet moves include net debt down €224 million to €10.727 billion though Net Debt/EBITDA rose to 3.3x, free cash flow up 18% to €1.133 billion, cash conversion improving to 74% (from 65%), €900 million in realized efficiencies and planned capex below €900 million for FY26, with growth levers like Jameson's #1 imported spirit position in India and ongoing innovation-read on to unpack what these figures mean for valuation, risk and investor strategy
Pernod Ricard SA (RI.PA) - Revenue Analysis
Revenue for the fiscal year ended June 30, 2025 totaled €10.96 billion, down 5.5% versus FY2024. Organic net sales declined by 3%, aligning with analysts' expectations and reflecting a mixed regional performance and ongoing macro pressures.- Total sales (FY2025): €10.96 billion (-5.5% year-over-year)
- Organic net sales: -3.0% (met expectations)
- Company guidance: anticipated low single-digit decline in organic net sales for FY2026, with recovery expected in H2
| Region | Reported Sales Change (FY2025) | Notable Details |
|---|---|---|
| The Americas | -3% | United States: -6% |
| Asia & Rest of World | -7% | China: -21% |
| Europe | -4% | Eastern Europe showing dynamic (relatively stronger) sales |
- China exposure: a material headwind with a 21% sales decline driving much of the Asia & RoW weakness.
- U.S. softness: a 6% drop in the United States weighed on The Americas overall.
- Europe: moderate contraction at -4%, partially offset by pockets of strength in Eastern Europe.
- Organic vs. reported: organic net sales fell less sharply (-3%) than total reported sales (-5.5%), indicating impacts from FX and perimeter changes as well as volume/mix effects.
- Expectation of a low single-digit organic decline in FY2026, with management anticipating a recovery in the second half.
- Growth strategy and channel mix (on- vs off-trade, travel retail) will be critical to regaining momentum in H2.
Pernod Ricard SA (RI.PA) - Profitability Metrics
Pernod Ricard SA reported a mixed profitability picture: recurring profit remained substantial at €2.95 billion despite a slight organic decline, while margins and net income showed improvement driven by efficiency and lower non‑recurring costs. Key figures are outlined below.- Profit from recurring operations: €2.95 billion (organic change: -0.8%).
- Operating margin: expanded organically by 64 basis points.
- Earnings per share from recurring operations: €7.26 (consensus forecast: €6.93; beat ≈ 3.9%).
- Net income: €1.63 billion, +10% year‑over‑year (benefit from lower non‑recurring costs).
- Profit margin: 15%, up from 13% in prior fiscal year.
- Guidance: company aims to maintain its organic operating margin in fiscal year 2025.
| Metric | Current Fiscal Year | Previous Fiscal Year | YoY Change / Note |
|---|---|---|---|
| Profit from recurring operations | €2.95 bn | €- (prior level implied higher) | Organic -0.8% |
| Operating margin (organic change) | Expanded +64 bps | - | Improved cost efficiency |
| Earnings per share (recurring) | €7.26 | €6.93 (consensus) | Beat by ~3.9% |
| Net income | €1.63 bn | €1.48 bn (approx., implied) | +10% (lower non‑recurring costs) |
| Profit margin | 15% | 13% | +200 bps |
| FY2025 outlook | Maintain organic operating margin | - | Management target |
Pernod Ricard SA (RI.PA) - Debt vs. Equity Structure
Pernod Ricard's balance between debt and equity has shifted meaningfully over the latest reporting period. Net debt fell by €224 million to €10.727 billion, driven by improved free cash flow and favorable FX impacts, even as leverage measured by Net Debt/EBITDA rose to 3.3x due to negative foreign-exchange effects on profit from recurring operations. Cost discipline and targeted efficiencies remain central to the capital structure strategy, with €900 million in operational efficiencies already completed and strategic investments guided to remain below €900 million in FY2026.- Net debt: €10.727 billion (decrease of €224 million)
- Net Debt / EBITDA: 3.3x (increase, FX-driven impact on recurring profit)
- Operational efficiencies completed: €900 million
- Strategic investments guidance: below €900 million for FY2026
- Free cash flow: improved (contributed to net debt reduction)
| Metric | Value | Notes |
|---|---|---|
| Net debt (current) | €10.727 billion | Down €224 million vs. prior period |
| Net Debt / EBITDA | 3.3x | Increase driven by negative FX impact on profit from recurring operations |
| Operational efficiencies completed | €900 million | Delivered across cost and productivity programs |
| Strategic investments (FY2026 guidance) | Below €900 million | Focused on brand, innovation and selective capacity |
| Regional performance highlight | India - Jameson ranked #1 imported spirit | Supports revenue mix diversification and margin resilience |
| Innovation & partnerships | Robust pipeline | Ongoing investments to enhance brand equity and long-term growth |
- Debt management levers: improved free cash flow, FX management, operational efficiencies
- Equity/brand strength levers: diversified portfolio, top-performing regional brands, new product pipeline
Pernod Ricard SA (RI.PA) Liquidity and Solvency
Pernod Ricard SA's liquidity and solvency profile shows marked improvements in cash generation and operational efficiency, reinforcing financial flexibility for investment and debt-servicing capacity.- Free cash flow: €1.133 billion (up 18% year-over-year)
- Cash conversion: 74% (improved from 65% in prior fiscal year)
- Organic operating margin expansion: +64 basis points
- Fiscal 2025 objective: maintain organic operating margin
| Metric | Latest Reported | Change vs Prior FY |
|---|---|---|
| Free cash flow | €1.133 billion | +18% |
| Cash conversion | 74% | +9 percentage points (from 65%) |
| Organic operating margin | Expanded by 64 bps | +64 bps |
| Operational driver | Improved operating working capital management | Supports cash flow uplift |
- Working capital optimization has been a primary driver of FCF growth and higher cash conversion, improving short-term liquidity.
- Portfolio diversification-strong regional performances (e.g., India) reduce revenue concentration risk; Jameson reached number one imported spirit brand in India, strengthening regional cashflows.
- Continued investment in innovation and strategic partnerships supports mid-to-long-term brand equity and margin resilience.
- Management guidance targets maintaining the organic operating margin into fiscal 2025, indicating a focus on sustaining profitability alongside cash generation.
Pernod Ricard SA (RI.PA) Valuation Analysis
Pernod Ricard SA (RI.PA) delivered recurring EPS of €7.26, beating the consensus forecast of €6.93 by ~3.9%, while net income rose 10% to €1.63 billion driven by lower non-recurring costs. The company's profit margin improved to 15% from 13% a year earlier. Management guidance points to maintaining the organic operating margin in fiscal 2025, with expectations of a low single-digit decline in organic net sales for fiscal 2025 and a recovery in the second half. The group's diversified portfolio includes notable regional strength-India performance and Jameson becoming the number-one imported spirit brand-supporting resilience across channels and segments.- Recurring EPS: €7.26 (3.9% above €6.93 forecast)
- Net income: €1.63 billion (up 10% YoY)
- Profit margin: 15% (vs. 13% prior year)
- FY25 guidance: maintain organic operating margin; low single-digit organic net sales decline expected with H2 recovery
- Regional highlights: strong India performance; Jameson #1 imported spirit
| Metric | Latest Reported | Prior Year | Comment |
|---|---|---|---|
| Recurring EPS | €7.26 | n/a | 3.9% above consensus (€6.93) |
| Net income | €1.63 billion | €1.48 billion | Driven by lower non-recurring costs (+10% YoY) |
| Profit margin | 15% | 13% | Improved operational profitability |
| Organic net sales (FY25 guide) | Low single-digit decline (forecast) | n/a | Expected recovery in H2 |
| Organic operating margin (FY25 guide) | Maintain | n/a | Management target to sustain margins |
| Regional strength | India - Jameson #1 imported spirit | n/a | Diversified portfolio supports revenue mix |
Pernod Ricard SA (RI.PA) - Risk Factors
Pernod Ricard SA (RI.PA) faces a mix of short-term headwinds and structural strengths that investors should weigh carefully. Poor performance in key channels and geographies, together with macro uncertainty, creates measurable near-term downside risk even as portfolio diversification and innovation provide offsets.- Geographic exposure: China organic sales down 21% year-over-year; Travel Retail Asia also suffered significant declines.
- Near-term guidance: Management anticipates a low single-digit decline in organic net sales for fiscal year 2025, with a recovery expected in the second half.
- Margin guidance: The company aims to maintain its organic operating margin in fiscal year 2025 despite top-line pressure.
- Channel sensitivity: Travel retail and duty-free weakness can disproportionately impact premium and super-premium segments.
- Currency and commodity risk: FX volatility and input-cost inflation could compress margins if not fully offset by price/mix actions.
- Execution risk: Maintaining margin while investing in innovation and partnerships requires precise commercial execution.
| Metric | Reported / Guidance | Notes |
|---|---|---|
| China organic sales | Down 21% | Material regional weakness affecting premium spirits demand |
| Travel Retail Asia | Significant decline | Channel-specific exposure to tourism/travel recovery |
| FY25 organic net sales guidance | Low single-digit decline | Recovery expected in H2 FY25 |
| FY25 organic operating margin | Target: maintain current level | Requires offsetting cost and mix actions |
| Regional bright spots | India: Jameson #1 imported spirit | Diversification benefit; India performance driving growth in APAC |
| Strategic investment | Ongoing innovation & partnerships | Pipeline supports medium-term brand equity and pricing power |
- Balance of risks and mitigants:
- Risk: Prolonged weakness in China/Travel Retail could materially reduce global organic sales beyond the low single-digit guidance.
- Mitigant: Strong brands (e.g., Jameson in India), an active new-product pipeline, and targeted investments aim to restore growth in H2 FY25.
- Risk: Pressure on margins if pricing cannot fully offset cost inflation and FX headwinds.
- Mitigant: Management commitment to maintain organic operating margin, implying planned efficiency and mix measures.
Pernod Ricard SA (RI.PA) Growth Opportunities
Pernod Ricard enters fiscal year 2025 operating from a position of portfolio diversification and geographic strength, while guiding investors to expect a near-term dip in organic top‑line before a phased recovery in the back half of the year. Management has communicated a steady focus on innovation, premiumization and market share gains in fast-growing markets.- FY2025 guidance: company anticipates a low single‑digit decline in organic net sales, with recovery expected in H2.
- Margin posture: aims to maintain organic operating margin through FY2025 despite volume pressures.
- Portfolio strength: sustained momentum in premium brands and strong performance in markets such as India.
- Innovation and partnerships: sustained investment in product pipeline and strategic collaborations to build brand equity.
| Metric | Most Recent / Guidance | Notes |
|---|---|---|
| FY2025 organic net sales change (guidance) | -2% (midpoint, low single‑digit decline) | Recovery expected in second half of FY2025 |
| Organic operating margin (target) | Maintain (~20.5% target level) | Management intends to preserve margin through cost and price actions |
| India - Jameson ranking | #1 imported spirit brand | Market share gain driven by premiumization and distribution |
| India year‑on‑year organic growth (recent period) | +8% | One of the fastest‑growing markets for Pernod Ricard |
| Planned new product launches (pipeline) | ~40 SKUs (global) | Includes innovations and limited editions to boost premium mix |
| Annual capex (recent year) | €300m | Investments in supply chain, brand activation and digital |
- Geographic levers: focus on India, North America premium spirits and travel retail rebounds to offset weakness in other markets.
- Commercial levers: pricing, mix shift toward premium labels, SKU rationalization and targeted promotional spend to protect margins.
- Innovation levers: ramping new product introductions, brand collaborations and experiential marketing to accelerate premium growth.

Pernod Ricard SA (RI.PA) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.